Cancer Family
Malignant Breast Neoplasm
CI-CAN-00000227Explore in graph →
Top-level2,628 active trials43 approved drugs310 evidence items
- NCIt
- C9335
- ICD-10
- C50
- DOID
- 1612
- Other
- 2 more codes
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000227Explore in graph →
Clinical trials
12,359 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,368)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT07102940 | Efti in Patients With Hormone Receptor Positive/HER2-neg Breast Cancer | not yet recruiting | Phase 2 | 50 | George Washington UniversityOTHER | 0 | Jun 11, 2026 | clinicaltrials |
| NCT07560475 | Exploratory Study of SHR-A1811 Via Different Administration Routes in Patients | not yet recruiting | Phase 2 | 60 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | Jun 11, 2026 | clinicaltrials |
| NCT07618923 | Neoadjuvant Dalpiciclib + AI → SHR-A1811 for HR+/HER2-Low Breast Cancer(TD-DASHER-01) | not yet recruiting | Phase 2 | 20 | Tang-Du HospitalOTHER | 0 | Jun 11, 2026 | clinicaltrials |
| NCT07643428 | Cancer Lipidome Adaptation and Resculping Through Omega-3 PUFAs in Breast Tumors(CLARA) | not yet recruiting | Phase 2 | 35 | Medical College of WisconsinOTHER | 1 | Jun 11, 2026 | clinicaltrials |
| NCT07643584 | De-Escalation of Axillary Management in Advanced Nodal Disease(DEMAND) | not yet recruiting | Phase 2 | 120 | University of Kansas Medical CenterOTHER | 0 | Jun 11, 2026 | clinicaltrials |
| NCT07639970 | Evaluation of [⁶⁸Ga/¹⁷⁷Lu]HT547: Safety, Biodistribution, and Dosimetry in Solid Tumors | not yet recruiting | Early Phase 1 | 20 | Hua PangOTHER | 0 | Jun 10, 2026 | clinicaltrials |
| NCT07635654 | Disease Extent in Stage IV Lobular Carcinoma: the Aid of Imaging and Liquid Biopsy Analyses(DELILA) | not yet recruiting | N/A | 43 | KU LeuvenOTHER | 0 | Jun 9, 2026 | clinicaltrials |
| NCT07623642 | A Phase II Study of GV20-0251 in Combination With Anti-PD-1 Monoclonal Antibodies in Patients With Unresectable, Locally Advanced, or Metastatic Solid Tumors. | not yet recruiting | Phase 2 | 227 | GV20 TherapeuticsINDUSTRY | 1 | Jun 8, 2026 | clinicaltrials |
| NCT07630103 | Efficacy and Safety of Trastuzumab Rezetecan or Trastuzumab Deruxtecan in Advanced Breast Cancer | not yet recruiting | Phase 2 | 100 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | Jun 5, 2026 | clinicaltrials |
| NCT07630948 | Adherence and Safety of Ribociclib Plus Aromatase Inhibitors in Patients With Early Stage, HR+ and HER2- Breast Cancer(riboADHERE) | not yet recruiting | Phase 4 | 90 | Institute of Oncology LjubljanaOTHER | 1 | Jun 5, 2026 | clinicaltrials |
| NCT07627269 | Late Scan Time-point Optimalisation of 18F-Fluoroestradiol for the Large Field-of-view (LAFOV) PET/CT Scanner. | not yet recruiting | N/A | 8 | University Medical Center GroningenOTHER | 1 | Jun 4, 2026 | clinicaltrials |
| NCT07357948 | Omission of Surgery for Triple-negative Breast Cancer in Complete Response After Neoadjuvant Chemo-immunotherapy(OMICHIR) | not yet recruiting | N/A | 150 | Institut CurieOTHER | 1 | Jun 3, 2026 | clinicaltrials |
| NCT07623226 | Super-Resolution Ultrasound Imaging for Assessing Response to Neoadjuvant Chemotherapy in Breast Cancer | not yet recruiting | — | 150 | Anhui Provincial Cancer HospitalOTHER | 1 | Jun 3, 2026 | clinicaltrials |
| NCT06812208 | Strategies to Decentralize Breast Ultrasound in Rwanda | not yet recruiting | N/A | 1,792 | Brigham and Women's HospitalOTHER | 1 | Jun 2, 2026 | clinicaltrials |
| NCT07616856 | Post-market Evaluation of LumiSystem: Intraoperative Margin Performance and Clinical Utility (IMPACT) Registry(IMPACT) | not yet recruiting | — | 1,500 | Lumicell, Inc.INDUSTRY | 0 | Jun 1, 2026 | clinicaltrials |
| NCT07618390 | A Phase ll, Interventional, Single-arm Study Evaluating the Efficacy and Safety of Inavolisib Plus Ribociclib and Fulvestrant in Chinese Patients With PIK3CA-mutant, HR-positive, HER2-negative Locally Advanced or Metastatic Breast Cancer. | not yet recruiting | Phase 2 | 160 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 0 | Jun 1, 2026 | clinicaltrials |
| NCT07619066 | A Phase II Study of Zongertinib Plus Fulvestrant in Participants With HR-positive/HER2-negative Advanced Breast Cancer Harboring HER2 Mutations.(AGATHA) | not yet recruiting | Phase 2 | 25 | MedSIROTHER | 0 | Jun 1, 2026 | clinicaltrials |
| NCT07405385 | REstoring Metabolic FLEXibility Through Combined Exercise in Breast Cancer Survivors: A Randomized Controlled Trial.(REFLEX) | not yet recruiting | N/A | 44 | University of Castilla-La ManchaOTHER | 1 | May 28, 2026 | clinicaltrials |
| NCT07610499 | Creating Opportunities For Personal Empowerment (COPE) In Women With Breast Cancer During First-Line Therapy: A Pilot Randomized Controlled Trial | not yet recruiting | N/A | 40 | M.D. Anderson Cancer CenterOTHER | 1 | May 28, 2026 | clinicaltrials |
| NCT07610525 | Blood and imagE-guided Optimization of Neoadjuvant Therapy in People With Early Stage Triple-negative Breast cancER - the BETTER Trial | not yet recruiting | Phase 2 | 200 | M.D. Anderson Cancer CenterOTHER | 1 | May 28, 2026 | clinicaltrials |
| NCT07610733 | Impact of Formulation Change on Ovarian Suppression in Young Breast Cancer Patients.(IFOCOS) | not yet recruiting | Phase 2 | 100 | Fudan UniversityOTHER | 0 | May 28, 2026 | clinicaltrials |
| NCT07578116 | Adding Surgery and Radiation to the Usual Treatment for HER2-Positive Breast Cancer That Had Already Spread at Diagnosis | not yet recruiting | Phase 3 | 562 | SWOG Cancer Research NetworkNETWORK | 0 | May 27, 2026 | clinicaltrials |
| NCT07599618 | Evaluation of a Patient-Centered Decision-Making Support Tool for Older Adults With Advanced Breast Cancer and Their Care Partners(PCDM) | not yet recruiting | N/A | 150 | University of RochesterOTHER | 1 | May 26, 2026 | clinicaltrials |
| NCT07575750 | Efficacy of Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) in Aromatase Inhibitor-induced Arthralgia (AIA)(AROVAGUE) | not yet recruiting | N/A | 60 | Institut Cancerologie de l'OuestOTHER | 1 | May 22, 2026 | clinicaltrials |
| NCT07601152 | Clinical and Biological Study of Early-onset Breast Cancer and the Influence of the Reproductive Cycle on the Aggressiveness of the Disease(ARTEMIS) | not yet recruiting | — | 1,000 | Institut Cancerologie de l'OuestOTHER | 1 | May 22, 2026 | clinicaltrials |
| NCT07604441 | Chemotherapy-Induced Peripheral Neuropathy - Additional Evaluation in Breast Cancer Survivors(NEURO-BREAC-02) | not yet recruiting | N/A | 28 | University Hospital Schleswig-HolsteinOTHER | 1 | May 22, 2026 | clinicaltrials |
| NCT07605195 | Research on the Whole-Process Intelligent Diagnosis and Treatment of Digital Breast Tomosynthesis Based on Deep Learning | not yet recruiting | N/A | 5,000 | Yunnan Cancer HospitalOTHER | 0 | May 22, 2026 | clinicaltrials |
| NCT07562399 | Adjuvant Endocrine Therapy Adherence Intervention Pilot in Rwanda | not yet recruiting | N/A | 224 | Dana-Farber Cancer InstituteOTHER | 2 | May 20, 2026 | clinicaltrials |
| NCT07599098 | Effects of a Pilates Studio Program on Quality of Life and Functional Capacity of Women Undergoing Breast Cancer Treatment(Cancer) | not yet recruiting | N/A | 50 | Federal University of MaranhaoOTHER | 0 | May 20, 2026 | clinicaltrials |
| NCT07313397 | Self-management Interventions to Reduce Cardiovascular Risks in Breast Cancer Survivors | not yet recruiting | N/A | 15 | University of Southern QueenslandOTHER | 1 | May 19, 2026 | clinicaltrials |
| NCT07596472 | Ultrasound Monitoring of Clipped Lymph Nodes to Predict Axillary Response After Chemotherapy in Breast Cancer | not yet recruiting | — | 150 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | May 19, 2026 | clinicaltrials |
| NCT07593196 | HER2-positive Metastatic Breast Cancer in Kazakhstan | not yet recruiting | — | 240 | AstraZenecaINDUSTRY | 1 | May 18, 2026 | clinicaltrials |
| NCT07593365 | Clinical Application of Vagus Nerve Stimulation Combined With Immunoregulatory T Cells in Alleviating Aromatase Inhibitor-Induced Pain | not yet recruiting | N/A | 216 | Peking University People's HospitalOTHER | 1 | May 18, 2026 | clinicaltrials |
| NCT07593651 | EXpander-based Versus Direct to Implant PRE-pectoral Breast Reconstruction: a Comparative Analysis of Surgical Outcomes(EXPRESSO) | not yet recruiting | — | 276 | IRCCS San RaffaeleOTHER | 0 | May 18, 2026 | clinicaltrials |
| NCT07593846 | The Comparison Between DEDTI BR and T/E BR(DETE-BR) | not yet recruiting | Phase 3 | 412 | West China HospitalOTHER | 1 | May 18, 2026 | clinicaltrials |
| NCT07583134 | Impact of Propranolol Strategies on Myocardial Injury After Breast Cancer Surgery(B-BIT) | not yet recruiting | Phase 4 | 100 | Chang-Ik YoonOTHER | 1 | May 15, 2026 | clinicaltrials |
| NCT07589101 | 5T4 Targeting Nanobody Probe for PET Imaging in Solid Tumors | not yet recruiting | N/A | 20 | Peking University Cancer Hospital & InstituteOTHER | 1 | May 15, 2026 | clinicaltrials |
| NCT07589699 | Trastuzumab Rezetecan (T-DXh) in HER2+ Breast Cancer With Non-pCR After TCbHP | not yet recruiting | Phase 4 | 59 | The First Affiliated Hospital with Nanjing Medical UniversityOTHER | 0 | May 15, 2026 | clinicaltrials |
| NCT07590583 | Biology Guided Therapy Recommendations for Treatment Determination of Hormone Receptor-Positive Advanced, Unresectable or Metastatic Breast Cancer, ENDORSE Trial | not yet recruiting | Phase 1 | 20 | City of Hope Medical CenterOTHER | 1 | May 15, 2026 | clinicaltrials |
| NCT07591532 | Pregnancy Outcomes After Breast Cancer in Young Women With Germline Pathogenic Variants in Genes Other Than BRCA(Beyond BCY) | not yet recruiting | — | 2,200 | Jules Bordet InstituteOTHER | 0 | May 15, 2026 | clinicaltrials |
| NCT07583719 | Effects of Moderate-intensity Interval Aerobic Exercise (MIIAE) on Inflammatory, Immune, Metabolic, Physical Fitness, and Quality of Life Parameters in Breast Cancer Patients Undergoing Radiotherapy. | not yet recruiting | N/A | 40 | Universidad Francisco de VitoriaOTHER | 0 | May 13, 2026 | clinicaltrials |
| NCT07580833 | A Study to Investigate the Effect of Food on the Bioavailability of Oral Paclitaxel Administered With Encequidar in Participants With Advanced Solid Tumors | not yet recruiting | Phase 1 | 46 | Health Hope PharmaINDUSTRY | 0 | May 12, 2026 | clinicaltrials |
| NCT07581795 | Study of Paclitaxel Polymeric Micelles Combined With HP and Adebelimab Versus Taxane Combined With HP as First-Line Treatment for Advanced HER2-Positive Breast Cancer(SPECTACLE) | not yet recruiting | Phase 2 | 140 | Fudan UniversityOTHER | 1 | May 12, 2026 | clinicaltrials |
| NCT07449273 | Breathing Interventions for Postoperative Breast Surgery Patients(BREATH-RCT) | not yet recruiting | N/A | 126 | Ondokuz Mayıs UniversityOTHER | 0 | May 11, 2026 | clinicaltrials |
| NCT07536867 | Comparison of Serratus Posterior Superior Intercostal Plane Block and Rhomboid Intercostal Block in Patients Undergoing Breast Cancer Surgery(SPSIP-RIB) | not yet recruiting | N/A | 60 | Antalya City HospitalOTHER | 1 | May 11, 2026 | clinicaltrials |
| NCT07578415 | Shared Decision Making for Patients With HER2-negative Metastatic Breast Cancer (SDM-01)(SDM-01) | not yet recruiting | N/A | 120 | Federico II UniversityOTHER | 0 | May 11, 2026 | clinicaltrials |
| NCT07575386 | The Effect of Video-Assisted Mindfulness-Based Breathing on Quality of Life and Mental Well-Being in Individuals With Breast Cancer | not yet recruiting | N/A | 50 | Ege UniversityOTHER | 0 | May 8, 2026 | clinicaltrials |
| NCT07570368 | Targeting Stress-Driven Inflammatory and Angiogenic Pathways With Brief ACT to Enhance Neoadjuvant Chemotherapy Response in Locally Advanced Breast Cancer | not yet recruiting | N/A | 54 | Universitas AirlanggaOTHER | 0 | May 6, 2026 | clinicaltrials |
| NCT07285993 | Detection and Outcomes in Metastatic Invasive Lobular Breast Cancer Through Novel F-18 FAP PET | not yet recruiting | Phase 2 | 15 | Randy YehOTHER | 1 | May 1, 2026 | clinicaltrials |
| NCT07562789 | Role of PCGEM1 in Breast Cancer | not yet recruiting | — | 90 | Assiut UniversityOTHER | 0 | May 1, 2026 | clinicaltrials |
Data updated 23 days agoSource updated Jun 11, 2026source: clinicaltrials